Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:723-730

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, X.-H.
Right arrow Articles by Allen, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, X.-H.
Right arrow Articles by Allen, D. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Ischemic biology - basic studies
Right arrow Ion channels/membrane transport
(Circulation Research. 1999;85:723-730.)
© 1999 American Heart Association, Inc.


Integrative Physiology

Role of Na+/H+ Exchanger During Ischemia and Preconditioning in the Isolated Rat Heart

Xiao-Hui Xiao, David G. Allen

From the Institute of Biomedical Research and Department of Physiology, University of Sydney, New South Wales, Australia.

Correspondence to Prof D.G. Allen, Institute of Biomedical Research and Department of Physiology, University of Sydney F-13, New South Wales, 2006 Australia. E-mail davida{at}physiol.usyd.edu.au


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—The role of the Na+/H+ exchanger in ischemia, reperfusion, and preconditioning was investigated in isolated perfused rat hearts. Contractile function, [Na+]i, and pHi were measured; ischemic damage was assessed by the recovery of developed pressure (DP) on reperfusion. After 30 minutes of ischemia, DP recovered to only 14±4% of preischemic control. In contrast, after preconditioning (3x5-minute periods of ischemia) followed by 30 minutes of ischemia, DP recovered to 75±4%. Hearts treated with the Na+/H+ exchange inhibitor 5-(N-methyl-N-isobutyl)amiloride (MIA) also showed an enhanced recovery after ischemia (DP 62±9%). Treatment with a low concentration of tetrodotoxin (TTX, 100 nmol/L), which blocks the persistent component of the Na+ current, had a small beneficial effect on recovery (DP 37±8%). Thirty minutes of ischemia caused a small [Na+]i rise (3.2±0.9 mmol/L); reperfusion resulted in a further [Na+]i increase (+11.9±2.5 mmol/L), which partially recovered over 30 minutes. Preconditioning did not change the [Na+]i rise during ischemia but abolished the large [Na+]i rise on reperfusion, and [Na+]i instead fell (-3.6±1.3 mmol/L). In the presence of MIA, the [Na+]i rise was unchanged from ischemia only; on reperfusion, [Na+]i fell (-3.7±0.9 mmol/L), similar to the preconditioned hearts. TTX abolished the [Na+]i rise during ischemia (+0.3±0.7 mmol/L), and the increase on reperfusion was similar to ischemia only. We conclude that the rise of [Na+]i during ischemia is caused by Na+ entry through persistent Na+ channels. The rise of [Na+]i on reperfusion is caused by activation of the Na+/H+ exchanger and is blocked by MIA and by preconditioning. It is known that the Na+/H+ exchanger is inhibited during ischemia; the present result suggests that this inhibition is prolonged into the early part of reperfusion by preconditioning. To test this hypothesis, we measured the time course of pHi recovery after ischemia and preconditioning. Preconditioning slowed the rate of pHi recovery after ischemia, providing further support for the hypothesis that preconditioning inhibits the Na+/H+ exchanger during early reperfusion. This inhibition of the Na+/H+ exchanger during reperfusion prevents Na+ entry, and therefore Ca2+ loading, and is part of the protective pathway involved in preconditioning.


Key Words: Na+/H+ exchanger • preconditioning • ischemia • reperfusion


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
In 1986, Murry et al1 first demonstrated that the myocardial damage associated with ischemia could be substantially reduced by several preceding short periods of ischemia; a phenomenon they termed preconditioning. This surprising and provocative finding has stimulated great interest in the underlying mechanism, which appears to represent an endogenous protective pathway. Substantial progress has been made in identifying possible triggers to preconditioning, which include adenosine, acetylcholine, {alpha}- and ß-adrenergic transmitters, bradykinin, and endothelin (for review, see Reference 2 ). These triggers bind to appropriate receptors that are G protein coupled and cause phospholipase C activation, production of inositol triphosphate and diacylglycerol, and eventually, activation of protein kinase C.3 4 Presumably, phosphorylation of some key proteins then results in protection of the myocardium from the damaging effects of ischemia and/or reperfusion. This latter part of the mechanism is the least well-defined. The ATP-sensitive K+ channel (KATP) is one of the phosphorylated proteins that provides protection. The initial evidence was that blockers of the KATP channel prevented preconditioning.5 Subsequently, it was shown that protein kinase C causes phosphorylated KATP and contributes to its activation.6 Recently, it has been suggested that it is the mitochondrial KATP channel that is involved,7 although the mechanism of protection remains unclear.

To understand how the protection invoked by preconditioning might occur, it is important to understand the possible mechanisms of myocardial damage during ischemia and/or reperfusion. One of the best established pathways is that protons produced during ischemia leave the myocytes on the Na+/H+ exchanger during reperfusion causing Na+ loading. Subsequently, Ca2+ loading occurs as Na+ leaves the cell on the Na+/Ca2+ exchanger. The resulting rise in [Ca2+]i is believed to trigger Ca2+-activated proteases and phospholipases that cause the cellular damage.8 9 In support of this theory is the observation that maneuvers which reduce Ca2+ entry at the time of reperfusion lead to myocardial protection.10 Another important finding is that inhibition of the Na+/H+ exchanger reduces myocardial damage on reperfusion.11 12 13

These findings suggest that coupled activation of the Na+/H+ exchanger and Na+/Ca2+ exchanger in response to intracellular acidosis may be part of the damage mechanism during reperfusion. If this is the case, modulation of this pathway might explain the beneficial effects of preconditioning. One version of this hypothesis was supported by Steenbergen et al. 14 They showed that after preconditioning the acidosis in the long period of ischemia was reduced, presumably because glycogen had been partly consumed in the preconditioning ischemias, and therefore the anaerobic lactic acid production was reduced.15 Consequently, the Na+ accumulation and the Ca2+ accumulation were reduced and the myocardial damage was lessened.14

It has long been suspected that the Na+/H+ exchanger would be inhibited during ischemia,16 and recent studies from our laboratory provide strong support for this view, although suggesting a different mechanism.17 We also established that the Na+/H+ exchanger reactivates rapidly on reperfusion, leading to a rapid rise of [Na+]i. If this rise in [Na+]i was prevented by an Na+/H+ exchange inhibitor, then the damaging effects of ischemia would be prevented. These observations led us to hypothesize that preconditioning might inhibit the Na+/H+ exchanger during reperfusion and prevent myocardial damage by this pathway. In the present study, we have investigated this possibility by means of measurements of [Na+]i and pHi during ischemia and reperfusion.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Heart Preparation
The preparation and monitoring of Langendorff-perfused rat hearts have been described in detail previously.17 18 Rats were supplied by Gore Hill Research Laboratories (Sydney), and the experiments were approved by the Animal Ethical Committee of the University of Sydney. Briefly, female Sprague-Dawley rats were anaesthetized with pentobarbitone, and the heart was rapidly excised. The aorta was cannulated and was retrogradely perfused with a modified Tyrode solution at a flow rate of 12 to 15 mL · min-1 · g-1 wet weight at 37°C. The perfusate had the following composition (mmol/L): NaCl 119, KCl 4, NaH2PO4 1.2, MgSO4 1.2, NaHCO3 25, CaCl2 1, and glucose 11. The solutions were continuously bubbled with 95% O2/5% CO2, which yielded pH 7.4. Hearts were stimulated at 2 Hz after excision of sinoatrial node and crushing the atrioventricular node. This is lower than the intrinsic rate ({approx}5 Hz) and helps to ensure adequate O2 delivery to the cells. Developed pressure (DP) was monitored with a balloon in the left ventricle.

Fluorescence Measurements
The hearts were placed in a chamber mounted on the stage of an inverted microscope modified for fluorescence measurements.17 Briefly, after measuring the autofluorescence, the hearts were loaded for 40 to 60 minutes by perfusion with the membrane-permeable acetoxymethyl ester form of fluorescent indicators for [Na+]i (SBFI) and for pHi (SNARF). The fluorescence signals from SBFI and SNARF were converted to [Na+]i and pHi using established calibration methods.17

Preliminary experiments with SNARF showed that during ischemia there was an initial acidosis of about 1 pH unit over 10 minutes, but after 15 minutes, the pHi showed a tendency to recover. We reasoned that this was because CO2, which is known to accumulate in the heart during ischemia,19 would tend to diffuse out of the epicardial cells into the stagnant solution surrounding the heart. To minimize this effect, we replaced the external solution in the bath with standard Tyrode equilibrated with 70% N2 and 30% CO2 at 10 and 20 minutes. This solution would have the dual effect of preventing any oxidative metabolism in the epicardial cells of the heart and preventing the loss of CO2 from the heart by diffusion. Under these conditions, pHi generally decreased smoothly during ischemia.

Ischemia, Preconditioning, and Drug Treatment
The ischemia was induced by stopping perfusion inflow to the heart while the heart was maintained at 35°C. The standard period of ischemia was 30 minutes; preconditioning consisted of 3 periods of 5 minutes of ischemia each followed by 5 minutes reperfusion and then followed by the standard 30 minutes of ischemia. 5-(N-methyl-N-isobutyl)amiloride (MIA) and tetrodotoxin (TTX) were applied 5 minutes before the 30 minutes of ischemia.

An expanded Materials and Methods section is available online at http://www.circresaha.org.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
DP and Contractures After Ischemia
We first established that preconditioning produced a substantial improvement in recovery from ischemia as shown in many earlier studies.14 20 Figures 1ADown and 1BDown show representative examples, and relevant data are summarized in Table 1Down. Note that during ischemia only (Figure 1ADown), the ischemic contracture (IC) is not prominent; by contrast the reperfusion contracture (RC) is very large and shows little recovery. There was little recovery of DP in this example. In 5 hearts, the IC was 33±12 mm Hg and appeared at 19±4 minutes. The RC was 87±13 mm Hg whereas the recovery of DP was 14±4%.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Mechanical performance of isolated rat hearts during and after ischemia. Records show left ventricular developed pressure (LVDP). A, 30 minutes of ischemia. Note large RC and absence of recovery of DP. B, 30 minutes of ischemia preceded by 3x5-minute periods of preconditioning ischemia. Note reduction in RC and substantial recovery of DP. C, Na+/H+ exchange inhibitor MIA (10 µmol/L) applied 5 minutes before the start of ischemia. Note absence of RC and substantial recovery of DP. D, Low concentration of TTX (100 nmol/L) applied 5 minutes before the start of recovery. Note moderate recovery of DP.


View this table:
[in this window]
[in a new window]
 
Table 1. Mechanical Performance During Ischemia and Reperfusion Under Various Conditions

Figure 1BUp illustrates the preconditioning protocol. Note that the RC is much smaller than in the ischemia-only record and that DP shows a good recovery. In 5 hearts, there was no significant difference in either the magnitude of the IC (28±7 mm Hg) or the time of first appearance (23±3 minutes) compared with ischemia only. However, the RC was much smaller (16±8 mm Hg) and the recovery of DP was much greater (75±4%).

To identify possible mechanisms of the elevations of [Na+]i during ischemia and on reperfusion, we blocked various Na+ influx pathways. Inhibitors of the Na+/H+ exchanger have been shown to reduce the rise in [Na+]i during ischemia,13 to reduce the [Na+]i during reperfusion,12 17 and to improve the mechanical recovery after ischemia.11 12 13 In the experiment shown in Figure 1CUp, the Na+/H+ exchanger inhibitor MIA (10 µmol/L) was applied 5 minutes before the start of ischemia. Note that there was little or no RC in this experiment and the DP showed a substantial recovery. In 5 experiments, the initial 5 minutes of exposure to MIA caused no significant change in DP (DP after 5 minutes of exposure was 88±6%). The IC (18±4 mm Hg) was not significantly different than ischemia whereas the RC (34±6 mm Hg) was significantly smaller than that during ischemia only. The recovery of DP (62±9%) was much greater than ischemia alone but not significantly different than preconditioned hearts.

Another possible source of Na+ influx into the cell during ischemia is through Na+ channels.21 22 We were particularly interested in the possibility that a persistent component of the Na+ channel (INa(P)) might contribute to Na+ influx during ischemia. There are several reasons for thinking that this component of Na+ influx might increase during ischemia. (1) INa(P) is less inactivated by the depolarized conditions that occur in ischemia.23 (2) INa(P) is preferentially increased during hypoxia.24 To test these ideas, we made use of the fact that 100 nmol/L TTX almost completely suppresses INa(P) but has very little effect on the conventional INa.23 Figure 1DUp shows that this concentration of TTX did not prevent regular contractions, confirming that normal INa was little affected. A typical IC developed and a moderately sized RC is apparent, and recovery of DP was intermediate in size between ischemia only and the enhanced recovery observed in preconditioning and MIA. In 6 hearts, DP did not change significantly in the initial 5 minutes of exposure (86±10%), IC was 31±4 mm Hg, RC was 36±8 mm Hg, and DP recovered to 37±8% (not significantly greater than ischemia only but significantly smaller than the preconditioned recovery).

[Na+]i During Ischemia and Reperfusion
Having determined that preconditioning improved the functional recovery after ischemia in a manner similar to that produced by inhibition of the Na+/H+ exchanger, we were interested in whether changes in [Na+]i were involved in these effects. The changes in [Na+]i during ischemia and reperfusion under various conditions are illustrated in Figure 2Down and summarized in Table 2Down. Figure 2ADown shows a small, slow rise of [Na+]i during 30 minutes of ischemia whereas reperfusion caused a large transient increase of [Na+]i, which partially recovered over 20 minutes. Under control conditions, [Na+]i was 7.2±0.3 mmol/L (n=24). In 6 hearts, the ischemic rise was 3.2±0.9 mmol/L; the increase on reperfusion was +11.9±2.5 mmol/L. Over 30 minutes of reperfusion, [Na+]i partially recovered to 13.4±3.0 mmol/L.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Records of [Na+]i before, during, and after ischemia. A, 30 minutes of ischemia. Note large rise in [Na+]i on reperfusion. B, 30 minutes of ischemia preceded by 3x5-minute preconditioning ischemias. Note decline in [Na+]i on reperfusion. C, Na+/H+ exchange inhibitor MIA (10 µmol/L) applied 5 minutes before the start of ischemia. Note fall of [Na+]i on reperfusion. D, Low concentration of TTX (100 nmol/L) applied 5 minutes before ischemia. Note absence of [Na+]i rise during ischemia but substantial [Na+]i rise on reperfusion.


View this table:
[in this window]
[in a new window]
 
Table 2. Effects of Preconditioning: Treatment With MIA and TTX and 5-Hz Stimulation on the Changes in [Na+]i During 30 Minutes of Ischemia and Reperfusion

The rise in [Na+]i during ischemia in the present experiments is relatively small, but we showed recently that when the stimulation frequency was higher (5 Hz), the rise of [Na+]i during a 10-minute period of ischemia was larger.17 We therefore measured the rise of [Na+]i during ischemia in 4 hearts paced at 5 Hz. The [Na+]i at 5 Hz was higher (11.5±1.3 mmol/L) than at 2 Hz (7.3±1.2 mmol/L), as expected,25 and after 30 minutes of ischemia, it reached 21.3±3.1 mmol/L, an increase of 9.8±1.6 mmol/L, which was larger than hearts stimulated at 2 Hz. The IC occurred at 7±1 minutes, which was much earlier than the 2-Hz group. Another possible reason that the rise in [Na+]i during ischemia might be smaller in the present experiments is that the extracellular and/or intracellular acidosis might be reduced in myocytes close to the surface (because CO2, which normally accumulates in the heart during ischemia,19 can diffuse into the surrounding perfusate). To prevent this, in 2 experiments we replaced the extracellular solution around the heart during ischemia with one containing 30% CO2 (pHo 6.6). The rise in [Na+]i in 30 minutes of ischemia in these experiments was 6.2±3.5 mmol/L, which is not significantly different than the control group at 2 Hz.

Figure 2BUp shows an example of the [Na+]i record during preconditioning and the subsequent ischemia and reperfusion. Note that the 3 short preconditioning ischemias have no significant effect on [Na+]i. The increase in [Na+]i during the subsequent long ischemia remained small, but a striking difference is apparent on reperfusion when the [Na+]i did not rise as in ischemia only but declined rapidly back to control level. In 5 hearts, the ischemic rise was 4.6±1.0 mmol/L, which is not significantly different than in ischemia only. The [Na+]i change on reperfusion was a fall (-3.6±1.3 mmol/L) to a level that was not significantly different than the preischemic level.

MIA had no effect on [Na+]i concentration over 5 minutes in control conditions nor any effect on the [Na+]i rise caused by the 30-minute periods of ischemia (4.4±0.6 mmol/L). In the presence of MIA, reperfusion caused an immediate decline in [Na+]i (-3.7±0.9 mmol/L) similar to that observed in the preconditioned heart. This final level was not significantly different than control and did not change thereafter.

TTX treatment (100 nmol/L) had no effect on [Na+]i concentration during the 5-minute application. However, the rise in [Na+]i caused by 30 minutes of ischemia was abolished by TTX treatment (+0.3±0.7 mmol/L). Reperfusion resulted in a relatively large transient increase of [Na+]i (+8.6±3.5 mmol/L), which was not significantly different from that observed during ischemia only. The [Na+]i level slowly declined so that after 30 minutes of reperfusion, [Na+]i concentration was 13.0±1.7 mmol/L, which was still significantly higher than the preischemic [Na+]i level.

pHi Measurements During Ischemia and Reperfusion
The absence of a rise in [Na+]i after preconditioning suggests that the Na+/H+ exchanger may be inhibited. If this were the case, we would expect the recovery of pHi after a preconditioned ischemia to be slower than ischemia only.26 Figure 3Down illustrates experiments designed to test this possibility. In 12 experiments, the resting pHi was 7.41±0.04. In 5 experiments, 30 minutes of ischemia caused pHi to decline to 6.08±0.17. On reperfusion, pHi recovered rapidly with an approximately exponential time course as shown in Figure 3ADown. The rate of recovery was characterized by the half-time of recovery, which was 26±5 seconds. In 7 experiments, preconditioned ischemia was examined, and a representative record is shown in Figure 3BDown. The acidosis in the 5-minute ischemias is smaller and recovers quickly, and the half-time of recovery after the first period of ischemia was 17±2 seconds. In contrast to ischemia only, the acidosis during the preconditioned ischemia was 6.55±0.18, which is significantly smaller than the ischemia only (P<0.05, unpaired t test). Despite the smaller acidosis, the recovery of acidosis is somewhat slower and the half-time was significantly longer, at 46±6 seconds. The rate of proton extrusion, which underlies these pHi recoveries, is a function of pHi, because both the extrusion mechanisms and the buffering are pH dependent.27 For this reason, we also measured the rate of pHi recovery at a constant pHi (6.8) and obtained the following values: 5 minutes of ischemia, 0.025±0.002 pHi unit/s, 30 minutes of ischemia only, 0.016±0.002 pH units/s, and preconditioned ischemia, 0.008±0.001 pH units/s. These values are all significantly different (P<0.001, one-way ANOVA) and confirm the results obtained with the half-times.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. pHi during ischemia, preconditioning, and reperfusion. A, pHi from heart before, during, and after 30 minutes of ischemia. The dots show an exponential fit to the recovery of pHi; the exponential used has a half-time of 31 seconds. B, pHi from another heart subjected to preconditioning before 30 minutes of ischemia. Note that the acidosis during ischemia is smaller, and the rate of recovery is somewhat slower. The dots show an exponential fit to the recovery; half-time is 51 seconds. C, Collected data showing the difference in half-times of pHi recovery from 5 minutes of ischemia (5 min I, n=9), 30 minutes ischemia (30 min I, n=7), and preconditioned ischemia (PC, n=9). The 30 minutes of ischemia vs preconditioning and the preconditioning vs 5 minutes of ischemia were significantly different, whereas the 5 minutes of ischemia vs 30 minutes of ischemia was not significantly different (one-way ANOVA).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
This work contains three novel findings. (1) The rise of [Na+]i during ischemia is prevented by a very low concentration of TTX. (2) The rise of [Na+]i observed during reperfusion is inhibited after preconditioning. (3) The rate of recovery of pHi after ischemia is slowed by preconditioning.

What Causes the [Na+]i Rise During Ischemia?
Na+ enters the heart by a variety of routes (channels and exchangers) and is extruded by the Na+ pump. An increase in [Na+]i must arise from increased influx and/or decreased efflux. There is evidence for all three possibilities during ischemia.

Inhibition of the Na+ Pump
The appearance of an ischemic contracture is usually taken to mean that the ATP is very low and the Na+ pump might be expected to inhibited. Strong support for this hypothesis is provided by Cross et al, 28 who showed that in a low-flow glucose-free model of ischemia the rise in [Na+]i occurred only after the Na+ pump was inhibited. In our experiments, at 2 Hz, an ischemic contracture is usually not apparent until relatively late (19 minutes), and we attribute this to using a low stimulation rate with improved metabolic status. The Na+ pump therefore remains effective for longer, and the [Na+]i is maintained at a low level for longer in ischemia. Thus, in our present experiments (2 Hz), we believe that inhibition of the Na+ pump makes relatively little contribution to the rise of [Na+]i during ischemia. In contrast, at 5 Hz, the ischemic contracture develops much earlier and the rise in [Na+]i during ischemia is much larger and presumably reflects inhibition of the Na+ pump (for discussion see Reference 1717 ).

Entry of Na+ on the Na+/H+ Exchanger
A number of studies have shown that inhibitors of the Na+/H+ exchanger applied before ischemia reduce the rate of rise of [Na+]i during ischemia.12 13 29 One interpretation of this observation is that the Na+/H+ exchanger is active during ischemia. However, there is strong evidence to suggest that the Na+/H+ exchanger is inhibited during ischemia. (1) [Na+]i does not rise at the rate one would predict for the degree of acidosis.17 (2) The pHi in ischemia is unaffected by inhibitors of the Na+/H+ exchanger.30 13 17 (3) Our earlier17 and present work show that MIA had no effect on the [Na+]i during ischemia. Obviously, if the Na+/H+ exchanger is inhibited, it cannot be the cause of the rise of [Na+]i during ischemia. An alternative interpretation of the effects of amiloride on [Na+]i during ischemia is that they arise from other effects of these drugs. Amiloride and even the high-affinity derivatives have many side effects including blocking Na+ channels.31 Haigney et al21 have suggested that the reduced [Na+]i during hypoxia produced by amiloride and its derivatives is caused by blocking Na+ channels rather than the Na+/H+ exchanger.

Na+ Entry Through Channels
Haigney et al 21 showed that in rat myocytes the Na+ rise caused by glucose-free hypoxia could be reduced by Na+ channel blockers including 60 µmol/L TTX. More recently, Van Emous et al 22 showed that the increase in [Na+]i during ischemia of the rat heart was substantially reduced by 200 µmol/L lidocaine. Note that in both of these studies relatively high concentrations of drugs were used that would block conventional INa channels. Our experiments extend these results by using a low concentration of TTX (100 nmol/L), which would not be expected to affect INa but instead would inhibit the INa(P).23 INa(P) remains active at the resting potential and is less inactivated by the depolarization that occurs during ischemia. In addition, INa(P) is activated by hypoxia so that its contribution to the Na+ influx would be expected to rise during ischemia.24 Thus, in our experiments, the main cause of the rise of [Na+]i during ischemia appears to be Na+ entry though the persistent Na+ channels. This finding is in agreement with the demonstration that the [Na+]i rise during anoxia is largely through INa(P).32

Why Does [Na+]i Rise on Reperfusion After Ischemia?
A number of published studies14 22 29 show that the [Na+]i falls on reperfusion, whereas in our study and other studies,12 33 the [Na+]i shows a transient rise followed by a fall. What is the cause of this variability between experiments? We suggest that the Na+ influx on reperfusion is either partly or completely masked by the activity of the Na+ pump.34 If the [Na+]i during ischemia is very high, then the Na+ pump will be maximally activated when metabolites return to normal on reperfusion.35 In this case, the Na+ efflux by the pump will be greater than the Na+ influx on the exchanger, and the [Na+]i will fall. Conversely, if the [Na+]i during ischemia is low, then the Na+ pump will have a low efflux rate, and the Na+ influx from the exchanger will be greater than the efflux, and [Na+]i will transiently rise.28

Why Does [Na+]i Not Rise on Reperfusion in the Preconditioned Heart?
Our second novel finding is that [Na+]i does not rise on reperfusion in the preconditioned heart. We have shown that the rise of [Na+]i after ischemia is caused by the Na+/H+ exchanger removing protons that have accumulated during ischemia. Why does [Na+]i fail to rise during reperfusion in the preconditioned heart? (1) If the preconditioned heart were not acidotic, then there should be no rise of [Na+]i on reperfusion. It is generally accepted that the acidosis is smaller in the preconditioned heart, and this is confirmed by our data.14 20 36 Typically, the acidosis in the preconditioned heart is {approx}75% of that in the ischemia-only heart, so we might expect the [Na+]i rise on reperfusion to be reduced to {approx}75% of its previous level, whereas, in fact, it changed from +11.9 to -3.6 mmol/L. Thus, the difference in acidosis during ischemia only versus preconditioned ischemia is not nearly enough to explain the differences in [Na+]i. (2) An alternative explanation is that the Na+/H+ exchanger, which is believed to be inhibited during ischemia,16 17 remains inhibited during reperfusion in the preconditioned heart. This possibility is reinforced by the MIA result, in which the mechanical recovery and [Na+]i changes are indistinguishable from the preconditioned heart. This interpretation is strongly supported by our third novel finding that the rate of recovery of pHi after ischemia is reduced in the preconditioned heart. Vandenberg et al26 showed that in the CO2/HCO3 perfused heart the Na+/H+ exchanger carried {approx}18% of the proton efflux, the remainder being carried by the Na+/HCO3- cotransporter, the lactate transporter, and CO2. The efflux in our experiments was reduced by {approx}50% by preconditioning, suggesting that the Na+/H+ exchanger appears to be making a greater contribution in our experiments than theirs. Surprisingly, we observed no increase in [Na+]i after MIA or preconditioning, whereas from their observations we would predict a residual [Na+]i rise caused by Na+ entry on the Na+/HCO3- cotransporter. (3) Another explanation would be that a different proton extrusion mechanism, which does not cause Na+ loading, has been activated by preconditioning, such as the vacuolar proton ATPase.37

We conclude that preconditioning appears to cause inhibition of the Na+/H+ exchanger during reperfusion for unknown reasons, and this contributes to protection from ischemic damage. Normally, on reperfusion, the rise of [Na+]i causes Ca2+ entry, and the elevated [Ca2+]i then initiates damage, probably by activating proteases and phospholipases and, in addition, by loading mitochondria with Ca2+ and impairing their function. If preconditioning prevents the rise in [Na+]i, this provides a simple explanation for the protection against damage that preconditioning produces.

What Inhibits the Na+/H+ Exchanger?
It appears from earlier work that the Na+/H+ exchanger is inhibited during ischemia. However, the mechanism of this inhibition is debated. Lazdunski et al 16 initially suggested that the inhibition arose from the extracellular acidosis, which is widely agreed to inhibit the exchanger.16 38 During ischemia, there is both an intracellular acidosis, which activates the exchanger, and an extracellular acidosis, which inhibits the exchanger. Thus, the net effect depends on the balance of these opposing effects. We have shown that under conditions that simulate both the extracellular and the intracellular acidosis of ischemia the exchanger appears to be active.18 39 Nevertheless, during ischemia, most pH measurements suggest that the exchanger is inhibited,13 17 30 and our own measurement of [Na+]i confirms this view.17 However, the exchanger is also inhibited by situations in which the metabolic status of the cardiac cell is reduced,17 40 41 but the nature of the inhibition is unclear. Simplistically, one could propose a phosphorylation site required for activation, but Goss et al41 could find no evidence for a phosphorylation site that was dephosphorylated by reduced ATP. Alternatively, one could propose that ATP has a direct effect on the activity of the exchanger, but because ATP does not decline rapidly in ischemia, it is difficult to explain the rapid inhibition of the Na+/H+ exchanger observed during ischemia. Furthermore, the metabolic status of cardiac myocytes improves on reperfusion, and this recovery is equally evident in preconditioned hearts as in ischemia only.15 Thus, if the mechanism by which the Na+/H+ exchanger is inhibited during ischemia is low ATP, then one would predict an equally rapid recovery on reperfusion in the preconditioned heart as in the ischemic-only heart.

There is a great deal of evidence that activation of protein kinase C during the long ischemia is essential to the protection that occurs on reperfusion.3 4 Thus, one could postulate that protein kinase C phosphorylates the exchanger causing inhibition and that, crucially, this inhibition does not reverse immediately on reperfusion and provides the observed protection against ischemic damage. Current evidence on the role of protein kinase C on the Na+/H+ exchanger is conflicting.42 Alternatively, protein kinase C might phosphorylate a phosphatase that maintains the exchanger dephosphorylated and inactive, and this effect is only reversed slowly on reperfusion. These and other possibilities, such as changes in the expression of the exchanger43 or changes in the distribution of exchanger between surface membrane and internal sites,44 require further investigation.

Significance
The successful protection against reperfusion damage provided by Na+/H+ exchanger inhibitors shows the critical role of the Na+/H+ exchanger in ischemic damage. Our results suggest that the endogenous protection provided by preconditioning also operates by inhibition of the Na+/H+ exchanger in the crucial early minutes of reperfusion. One prediction of our results is that Na+/H+ exchanger inhibitors will have no effect during ischemia but exert protection during a critical short period in the first few minutes of reperfusion.


*    Acknowledgments
 
This work was supported by the Australian National Heart Foundation.

Received January 13, 1999; accepted August 2, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136.[Abstract/Free Full Text]

2. Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS. Ischaemic preconditioning: present position and future directions. Cardiovasc Res. 1998;37:21–33.[Abstract/Free Full Text]

3. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586–590.[Abstract/Free Full Text]

4. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73–81.[Abstract/Free Full Text]

5. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223–233.[Abstract/Free Full Text]

6. Liu Y, Gao WD, O'Rourke B, Marbán E. Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine: implications for ischemic preconditioning. Circ Res. 1996;78:443–454.[Abstract/Free Full Text]

7. Liu Y, Sato T, O'Rourke B, Marbán E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463–2469.[Abstract/Free Full Text]

8. Tani M. Mechanisms of Ca2+ overload in reperfused ischemic myocardium. Annu Rev Physiol. 1990;52:543–559.[Medline] [Order article via Infotrieve]

9. Pierce GN, Czubryt MP. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol. 1995;27:53–63.[Medline] [Order article via Infotrieve]

10. Poole-Wilson PA, Harding DP, Bourdillon PDV, Tones MA. Calcium out of control. J Mol Cell Cardiol. 1984;16:175–187.[Medline] [Order article via Infotrieve]

11. Karmazyn M. Amiloride enhances postischemic ventricular recovery: possible role of Na+-H+ exchange. Am J Physiol. 1988;255:H608–H615.[Abstract/Free Full Text]

12. Tani M, Neely JR. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts: possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res. 1989;65:1045–1056.[Abstract/Free Full Text]

13. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991;68:1250–1258.[Abstract/Free Full Text]

14. Steenbergen C, Perlman M, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res. 1993;72:112–125.[Abstract/Free Full Text]

15. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66:913–930.[Abstract/Free Full Text]

16. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029–1042.[Medline] [Order article via Infotrieve]

17. Park CO, Xiao XH, Allen DG. Changes in intracellular Na+ and pH in rat heart during ischemia: role of Na+/H+ exchanger. Am J Physiol. 1999;276:H1581–H1590.[Abstract/Free Full Text]

18. Turvey SE, Allen DG. Changes in myoplasmic sodium concentration during exposure to lactate in perfused rat heart. Cardiovasc Res. 1994;28:987–993.[Abstract/Free Full Text]

19. Case RB, Felix A, Castellana FS. Rate of rise of myocardial PCO2 during early myocardial ischemia in the dog. Circ Res. 1979;45:324–330.[Abstract/Free Full Text]

20. Liu H, Cala PM, Anderson SE. Ischemic preconditioning: effects on pH, Na and Ca in newborn rabbit hearts during ischemia/reperfusion. J Mol Cell Cardiol. 1998;30:685–697.[Medline] [Order article via Infotrieve]

21. Haigney MC, Lakatta EG, Stern MD, Silverman HS. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation. 1994;90:391–399.[Abstract/Free Full Text]

22. Van Emous J, Nederhoff MG, Ruigrok TJ, Van Echteld C. The role of the Na+ channel in the accumulation of intracellular Na+ during myocardial ischemia: consequences for post-ischemic recovery. J Mol Cell Cardiol. 1997;29:85–96.[Medline] [Order article via Infotrieve]

23. Saint DA, Ju YK, Gage PW. A persistent sodium current in rat ventricular myocytes. J Physiol (Lond). 1992;453:219–231.[Abstract/Free Full Text]

24. Ju YK, Saint DA, Gage PW. Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol (Lond). 1996;497:337–347.[Abstract/Free Full Text]

25. Maier LS, Pieske B, Allen DG. Influence of stimulation frequency on [Na+]i and contractile function in Langendorff-perfused rat heart. Am J Physiol. 1997;273:H1246–H1254.[Abstract/Free Full Text]

26. Vandenberg JI, Metcalfe JC, Grace AA. Mechanisms of pHi recovery after global ischemia in the perfused heart. Circ Res. 1993;72:993–1003.[Abstract/Free Full Text]

27. Vaughan-Jones RD, Wu ML. pH dependence of intrinsic H+ buffering in the sheep cardiac Purkinje fibre. J Physiol (Lond). 1990;425:429–448.[Abstract/Free Full Text]

28. Cross HR, Radda GK, Clarke K. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: a 31P, 23Na and 87Rb NMR spectroscopic study. Magn Reson Med. 1995;34:673–685.[Medline] [Order article via Infotrieve]

29. Liu H, Cala PM, Anderson SE. Ethylisopropylamiloride diminishes changes in intracellular Na, Ca and pH in ischemic newborn myocardium. J Mol Cell Cardiol. 1997;29:2077–2086.[Medline] [Order article via Infotrieve]

30. Imai S, Shi AY, Ishibashi T, Nakazawa M. Na +/H+ exchange is not operative under low-flow ischemic conditions. J Mol Cell Cardiol. 1991;23:505–517.[Medline] [Order article via Infotrieve]

31. Kleyman TR, Cragoe EJ. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 1988;105:1–21.[Medline] [Order article via Infotrieve]

32. Russ U, Balser C, Scholz W, Albus U, Lang HJ, Weichert A, Scholkens BA, Gogelein H. Effects of the Na+/H+-exchange inhibitor Hoe 642 on intracellular pH, calcium and sodium in isolated rat ventricular myocytes. Pflugers Arch. 1996;433:26–34.[Medline] [Order article via Infotrieve]

33. Panagiotopoulos S, Daly MJ, Nayler WG. Effect of acidosis and alkalosis on postischemic Ca gain in isolated rat heart. Am J Physiol. 1990;258:H821–H828.[Abstract/Free Full Text]

34. Van Emous J, Schreur JH, Ruigrok TJ, Van Echteld C. Both Na+-K+ ATPase and Na+-H+ exchanger are immediately active upon post-ischemic reperfusion in isolated rat hearts. J Mol Cell Cardiol. 1998;30:337–348.[Medline] [Order article via Infotrieve]

35. Eisner DA, Smith TW. The Na-K pump and its effectors in cardiac muscle. In: Fozzard HA, Haber E, Jennings RB, Katz A, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations. New York, NY: Raven Press; 1991:863–902.

36. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 1991;84:2495–2503.[Abstract/Free Full Text]

37. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 1996;97:2391–2398.[Medline] [Order article via Infotrieve]

38. Vaughan-Jones RD, Wu ML. Extracellular H+ inactivation of Na+-H + exchange in the sheep cardiac Purkinje fibre. J Physiol (Lond). 1990;428:441–466.[Abstract/Free Full Text]

39. Cairns SP, Westerblad H, Allen DG. Changes in myoplasmic pH and calcium concentration during exposure to lactate in isolated rat ventricular myocytes. J Physiol (Lond). 1993;464:561–574.[Abstract/Free Full Text]

40. Weissberg PL, Little PJ, Cragoe EJJ, Bobik A. The pH of spontaneously beating cultured rat heart cells is regulated by an ATP-calmodulin-dependent Na+/H+ antiport. Circ Res. 1989;64:676–685.[Abstract/Free Full Text]

41. Goss GG, Woodside M, Wakabayashi S, Pouyssegur J, Waddell T, Downey GP, Grinstein S. ATP dependence of NHE-1, the ubiquitous isoform of the Na+/H+ antiporter. Analysis of phosphorylation and subcellular localization. J Biol Chem. 1994;269:8741–8748.[Abstract/Free Full Text]

42. Fliegel L, Wang H. Regulation of the Na+/H+ exchanger in the mammalian myocardium. J Mol Cell Cardiol. 1997;29:1991–1999.[Medline] [Order article via Infotrieve]

43. Dyck JR, Maddaford TG, Pierce GN, Fliegel L. Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc Res. 1995;29:203–208.[Medline] [Order article via Infotrieve]

44. Kurashima K, Szabo EZ, Lukacs G, Orlowski J, Grinstein S. Endosomal recycling of the Na+/H+ exchanger NHE3 isoform is regulated by the phosphatidylinositol 3-kinase pathway. J Biol Chem. 1998;273:20828–20836.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
G.-Y. Song, Y.-J. Wu, Y.-J. Yang, J.-J. Li, H.-L. Zhang, H.-J. Pei, Z.-Y. Zhao, Z.-H. Zeng, and R.-T. Hui
The accelerated post-infarction progression of cardiac remodelling is associated with genetic changes in an untreated streptozotocin-induced diabetic rat model
Eur J Heart Fail, October 1, 2009; 11(10): 911 - 921.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Li, M. Whiteman, Y. Y. Guan, K. L. Neo, Y. Cheng, S. W. Lee, Y. Zhao, R. Baskar, C.-H. Tan, and P. K. Moore
Characterization of a Novel, Water-Soluble Hydrogen Sulfide-Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide
Circulation, May 6, 2008; 117(18): 2351 - 2360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Iwata, Y. Katanosaka, T. Hisamitsu, and S. Wakabayashi
Enhanced Na+/H+ Exchange Activity Contributes to the Pathogenesis of Muscular Dystrophy via Involvement of P2 Receptors
Am. J. Pathol., November 1, 2007; 171(5): 1576 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Saini and N. S. Dhalla
Sarcolemmal cation channels and exchangers modify the increase in intracellular calcium in cardiomyocytes on inhibiting Na+-K+-ATPase
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H169 - H181.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Hale, J. A. Leeka, and R. A. Kloner
Improved Left Ventricular Function and Reduced Necrosis after Myocardial Ischemia/Reperfusion in Rabbits Treated with Ranolazine, an Inhibitor of the Late Sodium Channel
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 418 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala
Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L Belardinelli, J C Shryock, and H Fraser
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
Heart, July 1, 2006; 92(suppl_4): iv6 - iv14.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman
Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion
Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. B. Digerness, P. S. Brookes, S. P. Goldberg, C. R. Katholi, and W. L. Holman
Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. M Bers, W. H Barry, and S. Despa
Intracellular Na+ regulation in cardiac myocytes
Cardiovasc Res, March 15, 2003; 57(4): 897 - 912.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. G Allen and X.-H. Xiao
Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion
Cardiovasc Res, March 15, 2003; 57(4): 934 - 941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. C. Rothstein, K. L. Byron, R. E. Reed, L. Fliegel, and P. A. Lucchesi
H2O2-induced Ca2+ overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H598 - H605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Kohin, C. M. Stary, R. A. Howlett, and M. C. Hogan
Preconditioning improves function and recovery of single muscle fibers during severe hypoxia and reoxygenation
Am J Physiol Cell Physiol, July 1, 2001; 281(1): C142 - C146.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. R. Knight, A. H. Smith, D. M. Flynn, J. T. MacAndrew, S. S. Ellery, J. X. Kong, R. B. Marala, R. T. Wester, A. Guzman-Perez, R. J. Hill, et al.
A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 254 - 259.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
M. Avkiran, G. Gross, M. Karmazyn, H. Klein, E. Murphy, and K. Ytrehus
Na+/H+ exchange in ischemia, reperfusion and preconditioning
Cardiovasc Res, April 1, 2001; 50(1): 162 - 163.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. G Allen and X.-h. Xiao
Na+ entry during ischemia, reperfusion and preconditioning
Cardiovasc Res, April 1, 2001; 50(1): 164 - 166.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. W.T Fiolet
Reperfusion injury and ischemic preconditioning: two sides of a coin?
Cardiovasc Res, November 1, 2000; 48(2): 185 - 187.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
X-H. Xiao and D.G. Allen
Activity of the Na+/H+ exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart
Cardiovasc Res, November 1, 2000; 48(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. El Banani, M. Bernard, D. Baetz, E. Cabanes, P. Cozzone, A. Lucien, and D. Feuvray
Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine: Comparison between low- and zero-flow ischaemia
Cardiovasc Res, September 1, 2000; 47(4): 688 - 696.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. FINK, S. ERGÜN, D. KRALISCH, U. REMMERS, J. WEIL, and T. ESCHENHAGEN
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement
FASEB J, April 1, 2000; 14(5): 669 - 679.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
K. Imahashi, T. Nishimura, J. Yoshioka, and H. Kusuoka
Role of Intracellular Na+ Kinetics in Preconditioned Rat Heart
Circ. Res., June 8, 2001; 88(11): 1176 - 1182.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, X.-H.
Right arrow Articles by Allen, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, X.-H.
Right arrow Articles by Allen, D. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Ischemic biology - basic studies
Right arrow Ion channels/membrane transport